By Sharecast
Date: Friday 02 Jan 2026
By Sharecast
Date: Thursday 18 Dec 2025
By Benjamin Chiou
Date: Monday 13 Oct 2025
(Sharecast News) - IP Group said it is "encouraged" by the results of a recent clinical trial of a Metsara obesity drug, which could result in future sustainable royalties if approved by regulators.
| Currency | UK Pounds |
| Share Price | 59.50p |
| Change Today | 1.50p |
| % Change | 2.59 % |
| 52 Week High | 64.90 |
| 52 Week Low | 34.80 |
| Volume | 1,888,243 |
| Shares Issued | 883.43m |
| Market Cap | £525.64m |
| Beta | 1.41 |
| RiskGrade | 192 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 10-Aug-23 | 25-May-23 |
| Paid | 04-Sep-23 | 22-Jun-23 |
| Amount | 0.51p | 0.76p |
| Time | Volume / Share Price |
| 16:35 | 976,907 @ 59.50p |
| 16:35 | 99 @ 59.50p |
| 16:35 | 4,740 @ 59.50p |
| 16:35 | 2,235 @ 59.50p |
| 16:35 | 8,890 @ 59.50p |
You are here: research